Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?

Suppr

超能文献

作者信息

Sugiyama Toru

出版信息

Int J Clin Oncol. 2006 Jun;11(3):163. doi: 10.1007/s10147-006-0572-7.

DOI:10.1007/s10147-006-0572-7

PMID:16850120

Abstract

摘要

相似文献

Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?

Int J Clin Oncol. 2006 Jun;11(3):163. doi: 10.1007/s10147-006-0572-7.

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.紫杉醇联合卡铂与单药卡铂或环磷酰胺、阿霉素和顺铂的标准化疗方案用于卵巢癌女性患者的疗效比较：ICON3随机试验

Lancet. 2002 Aug 17;360(9332):505-15. doi: 10.1016/S0140-6736(02)09738-6.

Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.多药化疗方案在卵巢癌中的重要性：剂量强度分析

J Natl Cancer Inst. 1993 Nov 3;85(21):1732-42. doi: 10.1093/jnci/85.21.1732.

ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.ICON 2和ICON 3研究中既往未接受治疗的卵巢癌数据：迄今的结果。

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-23-S15-25.

Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.晚期卵巢癌的化疗：基于随机试验的当前护理标准

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347.

[Recent advances in ovarian cancer chemotherapy].[卵巢癌化疗的最新进展]

Gan To Kagaku Ryoho. 1992 Oct;19(12):1982-90.

ICON3 and chemotherapy for ovarian cancer.ICON3与卵巢癌化疗

Lancet. 2002;360(9350):2086-7; author reply 2088. doi: 10.1016/S0140-6736(02)11984-2.

Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.卵巢癌肉瘤：临床病理预后因素及含铂化疗方案的评估

Gynecol Oncol. 2008 Jan;108(1):136-40. doi: 10.1016/j.ygyno.2007.09.003. Epub 2007 Oct 23.

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.卵巢纯型透明细胞癌作为一种独特的组织学类型，在纯型晚期疾病中接受基于紫杉醇 - 铂类化疗的患者生存率有所提高。

Gynecol Oncol. 2004 Jul;94(1):197-203. doi: 10.1016/j.ygyno.2004.04.004.

Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer.

Semin Oncol. 1997 Aug;24(4 Suppl 11):S11-24-S11-27.

本文引用的文献

Historical control study of paclitaxel-carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer.紫杉醇-卡铂（TJ）与传统铂类化疗（CAP）用于上皮性卵巢癌的历史对照研究。

Int J Clin Oncol. 2006 Jun;11(3):221-8. doi: 10.1007/s10147-005-0555-0.

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.多西他赛-卡铂与紫杉醇-卡铂作为卵巢癌一线化疗方案的III期随机试验

J Natl Cancer Inst. 2004 Nov 17;96(22):1682-91. doi: 10.1093/jnci/djh323.

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.顺铂/紫杉醇与卡铂/紫杉醇作为卵巢癌一线治疗的随机临床试验。

J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9. doi: 10.1093/jnci/djg036.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.卡铂与紫杉醇联合方案对比顺铂与紫杉醇联合方案用于 III 期卵巢癌最佳减瘤术后患者的 III 期临床试验：一项妇科肿瘤学组研究

J Clin Oncol. 2003 Sep 1;21(17):3194-200. doi: 10.1200/JCO.2003.02.153. Epub 2003 Jul 14.

A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer.紫杉醇与卡铂治疗日本上皮性卵巢癌患者的可行性研究。

Oncol Rep. 2003 Jul-Aug;10(4):951-5.

Lancet. 2002 Aug 17;360(9332):505-15. doi: 10.1016/S0140-6736(02)09738-6.

A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer.卡铂和紫杉醇用于上皮性卵巢癌患者的I/II期研究。

Jpn J Clin Oncol. 2002 Apr;32(4):128-34.

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.顺铂联合紫杉醇与顺铂联合环磷酰胺治疗晚期上皮性卵巢癌女性的随机组间试验：三年结果

J Natl Cancer Inst. 2000 May 3;92(9):699-708. doi: 10.1093/jnci/92.9.699.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.环磷酰胺和顺铂与紫杉醇和顺铂治疗Ⅲ期和Ⅳ期卵巢癌患者的疗效比较。

N Engl J Med. 1996 Jan 4;334(1):1-6. doi: 10.1056/NEJM199601043340101.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验